The ASCO Post Podcast

IASLC WCLC 2020: Research in Mesothelioma, Small Cell Lung Cancer, and Drug Development

IASLC WCLC 2020: Updates From the ADAURA Trial and More

Prevalence of KRAS G12C Mutations Across Different Populations

More From GI21: Findings in Gastric Cancer, Cholangiocarcinoma, and Pancreatic Cancer

Findings From the 2021 Gastrointestinal Cancers Symposium

IDEA Collaboration: 3 vs 6 Months of Adjuvant Chemotherapy for Patients With Advanced Colon Cancer

News From the 2020 San Antonio Breast Cancer Symposium

More News From ASH: Whole-Genome Sequencing of Myeloproliferative Neoplasms and More

News From the 2020 ASH Annual Meeting & Exposition

COVID-19: Infection Rate Among Patients Undergoing Anticancer Therapy and Its Effect on Cancer Clinical Trials

Immune-Related Adverse Events and Survival Outcomes in NSCLC

Prostate Cancer Highlights From the 2020 ASTRO Annual Meeting

2020 ASTRO Annual Meeting: High-Impact Research

Recent FDA Approvals in Leukemia and Lymphoma

First-Line Atezolizumab vs Chemotherapy for PD-L1–Positive Metastatic NSCLC

Breast Cancer News From the ESMO Virtual Congress 2020

Lung Cancer Reports From the ESMO Virtual Congress 2020

ESMO Virtual Congress 2020: Spotlight on Genitourinary Cancers

ESMO Virtual Congress 2020: Findings in Breast and Head and Neck Cancers

Veliparib Plus Carboplatin/Paclitaxel in BRCA-Mutated, HER2-Negative Advanced Breast Cancer

From the Archive: Insights on Young-Onset Colorectal Cancer

Highlights From the IASLC Virtual Presidential Symposium

Decline in Non–Small Cell Lung Cancer Mortality From 2013 to 2016

Pathologic Complete Response in the I-SPY2 Trial

New Guidelines on Cervical Cancer Screening

Comparison of Two Combination Treatments in Localized Pancreatic Cancer

Cabozantinib for Patients With Advanced Bladder Cancer

Lenvatinib Plus Pembrolizumab for Patients With Advanced Gastric Cancer

Spotlight on Two Breast Cancer Studies From the ASCO20 Virtual Scientific Program

Multiple Myeloma Research From the ASCO20 Virtual Scientific Program

COVID-19 Research From the ASCO20 Virtual Scientific Program

Findings in Prostate Cancer From the ASCO20 Virtual Scientific Program

Plenary Research From the ASCO20 Virtual Scientific Program: Part 2

Plenary Research From the ASCO20 Virtual Scientific Program: Part 1

Coagulation Issues in Patients With COVID-19: Part 2

Coagulation Issues in Patients With COVID-19: Part 1

Highlights From the AACR Virtual Annual Meeting

Does Ibrutinib Offer a Protective Effect Against Pulmonary Injury in Patients With COVID-19?

Recent FDA Oncology/Hematology Approvals

Characteristics and Outcomes of Patients With Both COVID-19 and Cancer

Report on the ASH COVID-19 Registry for Malignant Hematology

End-of-Trial Findings From CLEOPATRA

Cancer Care Amid the COVID-19 Pandemic

Coronavirus, Patients With Cancer, and the Preparedness of the Institutions That Care for Them

Pulmonary Pathology of the Novel Coronavirus in Two Patients With Lung Cancer

News From the 2020 Multidisciplinary Head and Neck Cancers Symposium

News From the Genitourinary Cancers Symposium

Pembrolizumab Plus Chemotherapy in HER2-Negative Breast Cancer

H. pylori Infection and Gastric Cancer Risk

BEACON CRC: Patient-Reported Quality of Life Results